Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Friday, December 05, 2014 11:54:37 AM
bullish
ascending triangle breakout
$ACAD recent news/filings
## source: finance.yahoo.com
Tue, 25 Nov 2014 14:33:19 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 25, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and ...
read full: http://www.noodls.com/view/E872137554C9AFDAF39927396C8B06CE58B82E95
*********************************************************
Tue, 25 Nov 2014 14:00:00 GMT ~ ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
[Business Wire] - ACADIA Pharmaceuticals Inc. , a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervou
read full: http://finance.yahoo.com/news/acadia-pharmaceuticals-present-upcoming-investor-140000954.html
*********************************************************
Wed, 19 Nov 2014 21:09:23 GMT ~ ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
read full: http://biz.yahoo.com/e/141119/acad8-k.html
*********************************************************
Wed, 19 Nov 2014 18:04:21 GMT ~ ACADIA PHARMACEUTICALS INC Financials
read full: http://finance.yahoo.com/q/is?s=acad
*********************************************************
Thu, 13 Nov 2014 14:13:33 GMT ~ ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014
[at noodls] - SAN DIEGO--(BUSINESS WIRE)--Nov. 13, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address ...
read full: http://www.noodls.com/view/F21F300959865A3FD7B26B03DB1693C0EFE6D99B
*********************************************************
$ACAD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ACAD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ACAD/company-info
Ticker: $ACAD
OTC Market Place: Not Available
CIK code: 0001070494
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
Incorporated In: DE, USA
$ACAD share structure
## source: otcmarkets.com
Market Value: $3,039,003,338 a/o Dec 04, 2014
Shares Outstanding: 99,770,300 a/o Oct 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$ACAD extra dd links
Company name: ACADIA Pharmaceuticals, Inc.
Company website: http://www.acadia-pharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ACAD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ACAD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ACAD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/news - http://finance.yahoo.com/q/h?s=ACAD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ACAD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ACAD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ACAD
DTCC (dtcc.com): http://search2.dtcc.com/?q=ACADIA+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ACADIA+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ACADIA+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.acadia-pharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.acadia-pharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.acadia-pharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ACAD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001070494&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ACAD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ACAD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ACAD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ACAD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ACAD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ACAD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ACAD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ACAD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ACAD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ACAD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ACAD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ACAD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ACAD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ACAD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ACAD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ACAD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ACAD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ACAD
$ACAD DD Notes ~ http://www.ddnotesmaker.com/ACAD
Recent ACAD News
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 05/09/2024 08:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:10:16 PM
- Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview • Business Wire • 05/08/2024 08:05:00 PM
- Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship • Business Wire • 04/29/2024 08:16:00 PM
- Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024 • Business Wire • 04/24/2024 08:05:00 PM
- Acadia Pharmaceuticals annonce que la présentation de drogue nouvelle pour la trofinetide dans le traitement du syndrome de Rett a été acceptée pour dépôt et évaluation prioritaire par Santé Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada • Business Wire • 04/22/2024 01:04:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/19/2024 08:05:00 PM
- Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual Meeting • Business Wire • 04/17/2024 08:05:00 PM
- Acadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive Vice President, Head of Research and Development • Business Wire • 04/02/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference • Business Wire • 04/01/2024 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/15/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day • Business Wire • 03/13/2024 08:05:00 PM
- Oracle Soars 13% With Exceptional Growth and Boosts Nvidia Shares With Collaboration Announcement, and More • IH Market News • 03/12/2024 11:21:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:05:55 PM
- Acadia Pharmaceuticals Announces Top-Line Results from Phase 3 ADVANCE-2 Trial of Pimavanserin in Negative Symptoms of Schizophrenia • Business Wire • 03/11/2024 08:05:00 PM
- Acadia Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference on March 6, 2024 • Business Wire • 02/29/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:13:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:10:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:07:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 11:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:16:24 PM
- Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operating Overview • Business Wire • 02/27/2024 09:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/21/2024 09:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 12:08:13 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM